Patrick Trucchio
Stock Analyst at HC Wainwright & Co.
(2.26)
# 2,667
Out of 4,761 analysts
332
Total ratings
37.54%
Success rate
-0.39%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Patrick Trucchio
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HRMY Harmony Biosciences Holdings | Reiterates: Buy | $75 | $34.57 | +116.95% | 4 | Feb 19, 2025 | |
| DRUG Bright Minds Biosciences | Reiterates: Buy | $85 | $36.17 | +135.00% | 2 | Feb 19, 2025 | |
| ATAI Atai Life Sciences | Reiterates: Buy | $10 | $2.01 | +398.75% | 17 | Feb 13, 2025 | |
| CYBN Cybin | Maintains: Buy | $190 → $150 | $9.21 | +1,528.66% | 17 | Feb 13, 2025 | |
| CMPS COMPASS Pathways | Maintains: Buy | $40 | $4.24 | +844.51% | 13 | Feb 13, 2025 | |
| ARWR Arrowhead Pharmaceuticals | Reiterates: Buy | $80 | $20.07 | +298.60% | 22 | Feb 12, 2025 | |
| ALT Altimmune | Reiterates: Buy | $12 | $6.38 | +88.24% | 14 | Feb 5, 2025 | |
| IVVD Invivyd | Reiterates: Buy | $10 | $1.75 | +471.46% | 15 | Feb 4, 2025 | |
| BEAM Beam Therapeutics | Reiterates: Buy | $80 | $31.15 | +156.82% | 5 | Feb 3, 2025 | |
| SLN Silence Therapeutics | Reiterates: Buy | $75 | $4.79 | +1,465.76% | 22 | Feb 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $0.73 | +582.31% | 16 | Feb 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $110 | $9.63 | +1,042.86% | 22 | Jan 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $55 | $7.80 | +605.58% | 17 | Jan 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $1.42 | +606.71% | 15 | Jan 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $30 | $4.22 | +611.74% | 7 | Jan 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $70 | $12.84 | +445.38% | 12 | Jan 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $40 | $13.10 | +205.34% | 14 | Jan 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $100 | $29.83 | +235.29% | 17 | Jan 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $1.09 | +821.66% | 24 | Jan 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $25 | $2.04 | +1,128.50% | 15 | Jan 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $400 | $250.14 | +59.91% | 23 | Jan 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $60 | $5.93 | +911.80% | 14 | Jan 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $170 → $68 | $11.38 | +497.76% | 2 | Sep 23, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $230 → $20 | $0.28 | +6,964.64% | 2 | Dec 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $260 → $340 | $302.05 | +12.57% | 1 | Aug 18, 2021 |
Harmony Biosciences Holdings
Feb 19, 2025
Reiterates: Buy
Price Target: $75
Current: $34.57
Upside: +116.95%
Bright Minds Biosciences
Feb 19, 2025
Reiterates: Buy
Price Target: $85
Current: $36.17
Upside: +135.00%
Atai Life Sciences
Feb 13, 2025
Reiterates: Buy
Price Target: $10
Current: $2.01
Upside: +398.75%
Cybin
Feb 13, 2025
Maintains: Buy
Price Target: $190 → $150
Current: $9.21
Upside: +1,528.66%
COMPASS Pathways
Feb 13, 2025
Maintains: Buy
Price Target: $40
Current: $4.24
Upside: +844.51%
Arrowhead Pharmaceuticals
Feb 12, 2025
Reiterates: Buy
Price Target: $80
Current: $20.07
Upside: +298.60%
Altimmune
Feb 5, 2025
Reiterates: Buy
Price Target: $12
Current: $6.38
Upside: +88.24%
Invivyd
Feb 4, 2025
Reiterates: Buy
Price Target: $10
Current: $1.75
Upside: +471.46%
Beam Therapeutics
Feb 3, 2025
Reiterates: Buy
Price Target: $80
Current: $31.15
Upside: +156.82%
Silence Therapeutics
Feb 3, 2025
Reiterates: Buy
Price Target: $75
Current: $4.79
Upside: +1,465.76%
Feb 3, 2025
Reiterates: Buy
Price Target: $5
Current: $0.73
Upside: +582.31%
Jan 31, 2025
Reiterates: Buy
Price Target: $110
Current: $9.63
Upside: +1,042.86%
Jan 31, 2025
Reiterates: Buy
Price Target: $55
Current: $7.80
Upside: +605.58%
Jan 30, 2025
Reiterates: Buy
Price Target: $10
Current: $1.42
Upside: +606.71%
Jan 27, 2025
Reiterates: Buy
Price Target: $30
Current: $4.22
Upside: +611.74%
Jan 27, 2025
Maintains: Buy
Price Target: $25 → $70
Current: $12.84
Upside: +445.38%
Jan 27, 2025
Reiterates: Buy
Price Target: $40
Current: $13.10
Upside: +205.34%
Jan 27, 2025
Reiterates: Buy
Price Target: $100
Current: $29.83
Upside: +235.29%
Jan 27, 2025
Reiterates: Buy
Price Target: $10
Current: $1.09
Upside: +821.66%
Jan 27, 2025
Reiterates: Buy
Price Target: $25
Current: $2.04
Upside: +1,128.50%
Jan 13, 2025
Reiterates: Buy
Price Target: $400
Current: $250.14
Upside: +59.91%
Jan 10, 2025
Reiterates: Buy
Price Target: $60
Current: $5.93
Upside: +911.80%
Sep 23, 2022
Maintains: Buy
Price Target: $170 → $68
Current: $11.38
Upside: +497.76%
Dec 28, 2021
Maintains: Buy
Price Target: $230 → $20
Current: $0.28
Upside: +6,964.64%
Aug 18, 2021
Maintains: Outperform
Price Target: $260 → $340
Current: $302.05
Upside: +12.57%